These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 6203626
1. Vinblastine, bleomycin, and cis-platin as salvage therapy for MOPP treated patients with Hodgkin's lymphoma. Corder MP, Clamon GH, Wiesenfeld M. Cancer Invest; 1984; 2(3):193-8. PubMed ID: 6203626 [Abstract] [Full Text] [Related]
2. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. Duggan DB, Petroni GR, Johnson JL, Glick JH, Fisher RI, Connors JM, Canellos GP, Peterson BA. J Clin Oncol; 2003 Feb 15; 21(4):607-14. PubMed ID: 12586796 [Abstract] [Full Text] [Related]
3. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease. Piga A, Ambrosetti A, Todeschini G, Cetto G, Perona G, Cellerino R. Cancer Treat Rep; 1984 Feb 15; 68(7-8):947-51. PubMed ID: 6204754 [Abstract] [Full Text] [Related]
4. Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP. Santoro A, Viviani S, Villarreal CJ, Bonfante V, Delfino A, Valagussa P, Bonadonna G. Cancer Treat Rep; 1986 Mar 15; 70(3):343-8. PubMed ID: 2420444 [Abstract] [Full Text] [Related]
5. Advanced Hodgkin's disease: ABVD is better, yet is not good enough! Diehl V. J Clin Oncol; 2003 Feb 15; 21(4):583-5. PubMed ID: 12586791 [No Abstract] [Full Text] [Related]
6. Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy. Krikorian JG, Portlock CS, Rosenberg SA. Cancer; 1978 Jun 15; 41(6):2107-11. PubMed ID: 77716 [Abstract] [Full Text] [Related]
10. ABVD treatment of MOPP failures in Hodgkin's disease: a re-examination of goals of salvage therapy. Clamon GH, Corder MP. Cancer Treat Rep; 1978 Mar 15; 62(3):363-7. PubMed ID: 77188 [No Abstract] [Full Text] [Related]
12. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma]. Fu XH, Wang SS, Huang Y, Wang B, Huang HQ, Zhang L, Sun XF, Xu RH, Lin TY. Ai Zheng; 2006 Aug 15; 25(8):1013-8. PubMed ID: 16965685 [Abstract] [Full Text] [Related]
13. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma]. Niu Y, Shi YK, He XH, Feng FY, Zhou LQ, Gu DZ. Zhonghua Zhong Liu Za Zhi; 2008 Aug 15; 30(8):630-4. PubMed ID: 19102946 [Abstract] [Full Text] [Related]
14. Pediatric Hodgkin's disease. Oliapuram Jose B, Koerner P, Bertolone S, Patel CC, Spanos WJ, Paris KJ, Silverman CL, Yashar CM. J Ky Med Assoc; 2004 Mar 15; 102(3):104-6. PubMed ID: 15067795 [Abstract] [Full Text] [Related]
15. Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV). Case DC, Young CW, Lee BJ. Cancer; 1977 Apr 15; 39(4):1382-6. PubMed ID: 66972 [Abstract] [Full Text] [Related]
16. MOPP treatment of resistant Hodgkin's disease following ABVD failure. Cimino G, Anselmo AP, Marzullo A, Maurizi Enrici R, Mauro F, Papa G, Mandelli F. Tumori; 1983 Oct 31; 69(5):469-72. PubMed ID: 6196891 [Abstract] [Full Text] [Related]
17. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease. Longo DL, Glatstein E, Duffey PL, Young RC, Ihde DC, Bastian AW, Wilson WH, Wittes RE, Jaffe ES, Hubbard SM, DeVita VT. J Clin Oncol; 1997 Nov 31; 15(11):3338-46. PubMed ID: 9363863 [Abstract] [Full Text] [Related]